Staphylococcus Aureus Infection Clinical Trial
Official title:
Epidemiology of Rural MRSA : Is Livestock Contact a Risk Factor?
Verified date | May 2020 |
Source | National Institutes of Health Clinical Center (CC) |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Background:
- MRSA is a type of bacteria that causes serious health problems. It can cause severe
infections and is difficult to treat. MRSA has been found in a high number of people who work
with some kinds of livestock, such as pigs. Researchers want to study people in rural areas,
where more people work with or around livestock. They want to see if MRSA is more common or
causes more serious infections in these areas.
Objectives:
- To look at the relationship between livestock handling (especially pigs) and MRSA bacteria
in people in rural areas.
Eligibility:
- Participants in the Agricultural Health Study in Iowa, including those who are exposed
to livestock.
- Healthy volunteers who are not exposed to livestock.
Design:
- This study requires an initial visit and monthly follow-up surveys for 18 months.
- At the first visit, participants will have throat and nose swabs to collect cell and
bacteria samples. They will also complete a questionnaire about their health habits.
Other questions will ask about any work that brings them into contact with livestock
like cows, pigs, or chickens.
- Every month for the next 17 months, participants will complete another questionnaire to
record any changes in their health and livestock contact information. They will also
collect throat and nose swabs. They will send the questionnaires and the swabs to the
study researchers.
- Participants will be paid for the first visit and for every monthly survey and swab
collection they return.
- No treatment will be given as part of this protocol.
Status | Completed |
Enrollment | 1342 |
Est. completion date | May 21, 2020 |
Est. primary completion date | March 21, 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 6 Months to 100 Years |
Eligibility |
- INCLUSION CRITERIA: - Cohort A: Participant or child of participant in the Agricultural Health Study - Cohort B: Resident of Iowa EXCLUSION CRITERIA: - Cohort A: Age <8 months - Cohort B: Age <8 months |
Country | Name | City | State |
---|---|---|---|
United States | University of Iowa | Coralville | Iowa |
Lead Sponsor | Collaborator |
---|---|
National Cancer Institute (NCI) |
United States,
Fritz SA, Epplin EK, Garbutt J, Storch GA. Skin infection in children colonized with community-associated methicillin-resistant Staphylococcus aureus. J Infect. 2009 Dec;59(6):394-401. doi: 10.1016/j.jinf.2009.09.001. Epub 2009 Sep 9. — View Citation
Graham PL 3rd, Lin SX, Larson EL. A U.S. population-based survey of Staphylococcus aureus colonization. Ann Intern Med. 2006 Mar 7;144(5):318-25. — View Citation
Wertheim HF, Melles DC, Vos MC, van Leeuwen W, van Belkum A, Verbrugh HA, Nouwen JL. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis. 2005 Dec;5(12):751-62. Review. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Epidemiology of MRSA in AHS cohort | Establish the prevalence, molecular subtypes, and antibiotic resistance profiles of S. aureus in populations of rural Iowans, and determine risk factors for colonization. | ongoing | |
Primary | Epidemiology of MRSA in matched, population-based non-AHS group | Determine the incidence and molecular epidemiology of symptomatic S. aureus infections in rural Iowans. | ongoing |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04210505 -
Nasal Decolonization of Dialysis Patients Noses
|
Phase 4 | |
Not yet recruiting |
NCT05361135 -
18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia
|
N/A | |
Completed |
NCT02804711 -
A Clinical Trial to Evaluate a Recombinant Staphylococcus Aureus Vaccine (Escherichia Coli) in Healthy Adults
|
Phase 1 | |
Completed |
NCT02282605 -
Study of the Nasal Decolonisation of Staphylococcus Aureus (SA) and the Safety and Tolerability of XF-73 Nasal Gel in Healthy Subjects
|
Phase 1/Phase 2 | |
Recruiting |
NCT06319235 -
Clinical Trial to Demonstrate the Safety and Efficacy of DUOFAG®
|
Phase 1/Phase 2 | |
Enrolling by invitation |
NCT06317688 -
Effectiveness of Highly Purified Anhydrous (HPA) Lanolin Versus Extra-Virgin Coconut Oil in Preventing Subacute Lactation Mastitis
|
Phase 1 | |
Withdrawn |
NCT02741869 -
Photodisinfection for the Decolonization of Staphylococcus Aureus in Hemodialysis Patients
|
N/A | |
Completed |
NCT03966040 -
A Clinical Trial to Evaluate a Recombinant Staphylococcus Aureus Vaccine (Escherichia Coli) in Healthy Adults
|
Phase 1 | |
Completed |
NCT04803708 -
Bacteriophage Therapy TP-102 in Diabetic Foot Ulcers
|
Phase 1/Phase 2 | |
Recruiting |
NCT05117398 -
Dalbavancin Versus Standard Antibiotic Therapy for Catheter-related Bloodstream Infections Due to Staphylococcus Aureus
|
Phase 3 | |
Not yet recruiting |
NCT06456424 -
Bacteriophage Therapy for Methicillin-Sensitive Staphylococcus Aureus Prosthetic Joint Infection
|
Phase 1/Phase 2 | |
Completed |
NCT02820883 -
A Study of a Recombinant Staphylococcus Aureus Vaccine (Escherichia Coli) in Healthy Adults
|
Phase 0 | |
Active, not recruiting |
NCT01879761 -
Immune Resolution After Staphylococcus Aureus Bacteremia
|
||
Recruiting |
NCT00532324 -
Community-Acquired Methicillin Resistant Staphylococcus Aureus Colonization in Pregnant Women and Infections in Newborns
|
N/A | |
Completed |
NCT04503252 -
Probability of Target Attainment With Standard Intermittent Bolus Administration of Cefazolin in Patients With Complicated Infections Caused by Staphylococcus Aureus
|
||
Recruiting |
NCT06368856 -
Pharmacology of Mupirocin in Nasal Application in Healthy Volunteers: Monocentric Study
|
Phase 1 | |
Not yet recruiting |
NCT05899140 -
Adjunctive Clindamycin for the Treatment of Skin and Soft Tissue Infections, a Randomized Controlled Trial
|
Phase 4 | |
Completed |
NCT01792804 -
Staphylococcus Aureus Bacteremia Antibiotic Treatment Options
|
Phase 3 | |
Enrolling by invitation |
NCT04897971 -
Serum Based Diagnosis of and Monitoring of Infection Recovery in Orthopedic Spine Implant Infections
|
||
Completed |
NCT00572910 -
A Study to Evaluate the Safety and Immunogenicity of V710 in Adults With Kidney Disease on Hemodialysis (V710-005)(COMPLETED)
|
Phase 2 |